Literature DB >> 16281425

How FDA currently makes decisions on clinical studies.

Robert Temple1.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 16281425     DOI: 10.1191/1740774505cn097oa

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


× No keyword cloud information.
  9 in total

Review 1.  A framework for the analysis of heterogeneity of treatment effect in patient-centered outcomes research.

Authors:  Ravi Varadhan; Jodi B Segal; Cynthia M Boyd; Albert W Wu; Carlos O Weiss
Journal:  J Clin Epidemiol       Date:  2013-05-04       Impact factor: 6.437

2.  Good decision making requires good communication.

Authors:  Baruch Fischhoff
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

Review 3.  Drug development for rare mitochondrial disorders.

Authors:  Orest Hurko
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

4.  Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment.

Authors:  Paul M Cinciripini; Charles E Green; Jason D Robinson; Maher Karam-Hage; Jeffrey M Engelmann; Jennifer A Minnix; David W Wetter; Francesco Versace
Journal:  Psychopharmacology (Berl)       Date:  2017-03-08       Impact factor: 4.530

5.  Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders: A pilot randomized controlled trial.

Authors:  Julia D Buckner; Michael J Zvolensky; Anthony H Ecker; Norman B Schmidt; Elizabeth M Lewis; Daniel J Paulus; Paula Lopez-Gamundi; Kathleen A Crapanzano; Jafar Bakhshaie
Journal:  Behav Res Ther       Date:  2018-10-26

6.  A sequential multiple assignment randomized trial for cocaine cessation and relapse prevention: Tailoring treatment to the individual.

Authors:  Joy M Schmitz; Angela L Stotts; Anka A Vujanovic; Michael F Weaver; Jin H Yoon; Jessica Vincent; Charles E Green
Journal:  Contemp Clin Trials       Date:  2017-12-26       Impact factor: 2.226

7.  Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial.

Authors:  Luba Yammine; Charles E Green; Thomas R Kosten; Constanza de Dios; Robert Suchting; Scott D Lane; Christopher D Verrico; Joy M Schmitz
Journal:  Nicotine Tob Res       Date:  2021-08-29       Impact factor: 4.244

8.  Pilot testing the effectiveness of whether a survey-driven tablet-based intervention increased willingness of Black women to attend to an initial PrEP clinic visit: The protocol for the pilot randomized controlled trial design and methods.

Authors:  Mandy J Hill; Angela M Heads; Charles Green; Robert Suchting; Angela L Stotts
Journal:  Contemp Clin Trials Commun       Date:  2022-08-27

9.  Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial.

Authors:  Luba Yammine; Thomas R Kosten; Paul M Cinciripini; Charles E Green; Janet C Meininger; Jennifer A Minnix; Thomas F Newton
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.